1. Home
  2. BCAB vs MSAI Comparison

BCAB vs MSAI Comparison

Compare BCAB & MSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • MSAI
  • Stock Information
  • Founded
  • BCAB 2007
  • MSAI 1995
  • Country
  • BCAB United States
  • MSAI United States
  • Employees
  • BCAB N/A
  • MSAI N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • MSAI
  • Sector
  • BCAB Health Care
  • MSAI
  • Exchange
  • BCAB Nasdaq
  • MSAI Nasdaq
  • Market Cap
  • BCAB 31.5M
  • MSAI 25.9M
  • IPO Year
  • BCAB 2020
  • MSAI N/A
  • Fundamental
  • Price
  • BCAB $0.68
  • MSAI $0.73
  • Analyst Decision
  • BCAB Hold
  • MSAI Strong Buy
  • Analyst Count
  • BCAB 3
  • MSAI 1
  • Target Price
  • BCAB $1.00
  • MSAI $2.50
  • AVG Volume (30 Days)
  • BCAB 1.1M
  • MSAI 108.8K
  • Earning Date
  • BCAB 11-06-2025
  • MSAI 11-11-2025
  • Dividend Yield
  • BCAB N/A
  • MSAI N/A
  • EPS Growth
  • BCAB N/A
  • MSAI N/A
  • EPS
  • BCAB N/A
  • MSAI N/A
  • Revenue
  • BCAB $11,000,000.00
  • MSAI $5,591,000.00
  • Revenue This Year
  • BCAB N/A
  • MSAI $24.16
  • Revenue Next Year
  • BCAB N/A
  • MSAI $102.22
  • P/E Ratio
  • BCAB N/A
  • MSAI N/A
  • Revenue Growth
  • BCAB N/A
  • MSAI N/A
  • 52 Week Low
  • BCAB $0.24
  • MSAI $0.52
  • 52 Week High
  • BCAB $2.53
  • MSAI $3.33
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 63.71
  • MSAI 51.92
  • Support Level
  • BCAB $0.60
  • MSAI $0.68
  • Resistance Level
  • BCAB $0.84
  • MSAI $0.82
  • Average True Range (ATR)
  • BCAB 0.08
  • MSAI 0.05
  • MACD
  • BCAB 0.02
  • MSAI 0.01
  • Stochastic Oscillator
  • BCAB 62.14
  • MSAI 52.35

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About MSAI Infrared Cameras Holdings Inc.

MultiSensor AI Holdings Inc build and deploy intelligent multi-sensing platforms incorporating edge and cloud software solutions that leverage artificial intelligence (AI). It is a provider of sensing systems built around high-resolution thermal imagers, visible and acoustic imagers, as well as vibration and laser spectroscopy sensors, that perceive and measure heat, sound, vibration, and gas in industrial assets and the surrounding environment, helping companies gain insight to protect and manage their most important assets and infrastructure. It also offers a wide range of form factors for its sensor devices, including, among other form factors, small to large handheld designs with built-in displays and controls, and fixed-mounted single- and multi-sensor camera sensor systems.

Share on Social Networks: